Discover 999 paid clinical trials in Rochester, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 999
An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)
Location: Rochester MN, Toronto
Sponsor: ToLymph Inc.
Sex: All
Age: 18 - 70+
Code: NCT06693336
Phase 2, Recruiting
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Rochester MN, Madison WI, Iowa City IA, Chicago IL,
Sponsor: Replimune Inc.
Sex: All
Age: 0+
Code: NCT06581406
Phase 2, Phase 3, Recruiting
Real-Time Cholangioscopy Artificial Intelligence Evaluation of Biliary Strictures
for
Biliary Stricture
Location: Rochester MN, Worcester MA
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT05779436
Recruiting
Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
for
Bone Sarcoma, Soft Tissue Sarcoma
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06409013
Recruiting
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
for
Nodal Marginal Zone Lymphoma
Location: Rochester MN, Columbus OH, Toronto, New York NY,
Sponsor: International Extranodal Lymphoma Study Group (IELSG)
Sex: All
Age: 18+
Code: NCT05700149
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study
for
Gastric Adenocarcinoma,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 70+
Code: NCT05753306
Phase 2, Recruiting
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
for
Recurrent Glioblastoma, Recurrent WHO Grade 4 Glioma
Location: Rochester MN
Sponsor: Academic and Community Cancer Research United
Sex: All
Age: 18+
Code: NCT06160206
Phase 2, Recruiting
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
for
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Location: Rochester MN, Columbus OH, Salt Lake City UT
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05091424
Phase 1, Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
for
Prostate Cancer
Location: Rochester MN, Omaha NE, St Louis MO, Fort Wayne IN,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT05803941
Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma